FundedIQ
Biotechnology

OssDsign AB: Funding, Investors & Team (Sep 2026)

OssDsign was founded in May 2011 by Professor Håkan Engqvist, Dr Thomas Engstrand, Bo Qwarnstrom, Jonas Åberg, Uppsala University AB and other leading clinical, preclinical and materials researchers and engineers. The key people in the company are presented below. OssDsign has in addition developed a network of international experts in Clinical Affairs, Regulatory and Business Development.

www.ossdsign.com LinkedIn Uppsala, Sweden 11-50 employees
Biotechnology Clinical Trials Health Care Medical B2B B2C
Total raised
$30.2M
Rounds
2
Latest
Undisclosed round
Jun 2025

OssDsign AB has raised $30.2M across 2 funding rounds on record, the most recent an undisclosed round of $16.6M announced in Jun 2025.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

OssDsign AB Company Profile and Key Stats

Total funding raised
$30.2M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$16.6M in Jun 2025
Employees
11-50
reported band
Headquarters
Uppsala, Sweden

Latest funding round on record: Jun 2025.

OssDsign AB Funding Rounds

Date
Round
Amount
Undisclosed round
$16.6M
Undisclosed round
$13.6M

OssDsign AB raised $13.6M in an undisclosed round announced in Sep 2023.

1.8 years later, an undisclosed round of $16.6M was announced in Jun 2025.

OssDsign AB Founders and Leadership Team

Name
Role
Contact
Hakan Engqvist
Founder
Thomas Engstrand
Founder

No contact details are on record for this team yet.

OssDsign AB Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
688
$4.2M

OssDsign AB's latest round of $16.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like OssDsign AB in Biotechnology and Uppsala

Companies Similar to OssDsign AB

Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…

Series B $15.5M

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic…

Undisclosed round $1.4M

Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.

Pre-Seed $740k

Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…

Undisclosed round $790k

OncoZenge is a Swedish pharmaceutical company. It develops better products for the supportive care of cancer…

Undisclosed round $1.6M

Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for…

Undisclosed round $150k

Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for…

Undisclosed round $2.1M

Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular…

Undisclosed round $20.0M

Bio-Works was established in 2006 and specializes in creating, producing, and distributing cutting-edge…

Undisclosed round $60k

Verigraft AB is a biotech company that creates personalized tissue-engineered transplants for use in…

Undisclosed round $11.9M

Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…

Undisclosed round $9.3M

ArgusEye is a biotech firm that offers sensor solutions for instant identification of biological systems and…

Undisclosed round $7.4M

OssDsign AB Funding FAQs

What does OssDsign AB do?

OssDsign was founded in May 2011 by Professor Håkan Engqvist, Dr Thomas Engstrand, Bo Qwarnstrom, Jonas Åberg, Uppsala University AB and other leading clinical, preclinical and materials researchers and engineers. The key people in the company are presented below. OssDsign has in addition developed a network of international experts in Clinical Affairs, Regulatory and Business Development.

How much funding has OssDsign AB raised?

OssDsign AB has raised $30.2M across 2 rounds on record. The most recent is an undisclosed round of $16.6M announced in Jun 2025.

When did OssDsign AB last raise funding?

OssDsign AB's most recent funding round on record is an undisclosed round of $16.6M, announced in Jun 2025.

Who founded OssDsign AB?

FundedIQ lists Hakan Engqvist (Founder), Thomas Engstrand (Founder) at OssDsign AB.

Where is OssDsign AB headquartered?

OssDsign AB is based in Uppsala, Uppsala Lan, Sweden.

How many employees does OssDsign AB have?

OssDsign AB is in the 11-50 employee band.

How does OssDsign AB's funding compare to other Biotechnology startups?

OssDsign AB's latest round of $16.6M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's OssDsign AB Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for OssDsign AB is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.